下载App
扫码立即下载
  • 下载App

    扫码立即下载

  • 在线客服

    登录后咨询在线客服
+
恭喜您!
成功领取价值超 5000港元/年的高级行情
前往体验 >>
多维分析
公司估值 资金追踪 卖空分析
02500 启明医疗-B
14.780
+0.300+2.07%
显示同比
不显示
隐藏空行
(FY)2021/12/31(Q6)2021/06/30(FY)2020/12/31(Q6)2020/06/30
Per Share IndicaTor
Operating Cash Flow Per Share
-90.34% -1.2672 -71.71% -0.5621 20.47% -0.6658 -- -0.3274
Cash Flow Per Share
-29.26% 0.7806 297.69% 2.4145 -82.18% 1.1034 -- -1.2214
Operating Income Per Share
48.73% 1.1533 136.06% 0.652 20.44% 0.7754 -- 0.2762
Net Asset Per Share
17.62% 12.6067 63.87% 13.3125 27.87% 10.7179 -- 8.124
Basic Earning Per Share
-94.44% -1.0396 -159.47% -0.3125 60.74% -0.5347 -- -0.1204
Diluted  Earning Per Share
-94.44% -1.0396 -159.47% -0.3125 60.74% -0.5347 -- -0.1204
Profitability
Gross Profit Ratio
-5.27% 77.993% -5.72% 78.609% -1.34% 82.334% -- 83.379%
Operating Profit Ratio
-30.27% -87.972% -20.3% -46.261% 49.96% -67.529% -- -38.453%
Net Profit Ratio
-34.81% -89.307% -14.83% -48.989% 59.42% -66.245% -- -42.664%
Earning Before Tax Ratio
-34.86% -90.789% -14.84% -48.987% 58.84% -67.323% -- -42.655%
ROE
-65.92% -9.056% -82.99% -2.612% 74.84% -5.458% -- -1.427%
ROA
-71.35% -8.031% -94.23% -2.340% 70.89% -4.687% -- -1.205%
Yield Quality
Operating Cash To Total Revenue
-27.97% -109.872% 27.26% -86.214% 33.96% -85.857% -- -118.528%
Capital Structure
Debt Assets Ratio
-12.48% 9.348% -35.69% 8.746% -37.11% 10.680% -- 13.601%
Equity Multipler
-0.68% 1.124 -4.87% 1.1042 -6.31% 1.1318 -- 1.1608
Debt Equity Ratio
-13.76% 10.312% -39.12% 9.584% -41.55% 11.957% -- 15.742%
Current Assets To tatal Assets
-13.49% 67.319% 8.68% 79.797% -1.7% 77.820% -- 73.426%
Non Current Assets To Total Assets
47.34% 32.681% -23.97% 20.203% 6.46% 22.180% -- 26.574%
Current Liabilities To tatal Liabilities
-50.34% 43.662% 2.03% 89.464% -3.63% 87.928% -- 87.682%
Non Current Liabilities To Total Liabilities
366.69% 56.338% -14.47% 10.536% 37.75% 12.072% -- 12.318%
Solvency
Current Ratio
99.04% 16.4943 65.63% 10.1984 62.19% 8.2868 -- 6.1572
Quick Ratio
97.32% 16.0602 65.53% 10.0414 60.67% 8.1391 -- 6.066
Operating Profit To Current Liabilities
-281.64% -1.7544 -177.67% -0.2622 17% -0.4597 -- -0.0944
Operrating Cash Flow To Current Liabilities
-274.9% -2.1911 -67.88% -0.4887 -9.54% -0.5845 -- -0.2911
Share Equity Without Minority Interest To Total Liabilities
15.04% 9.5174 63.47% 10.3545 69.73% 8.273 -- 6.3341
Operating Cash Flow To Total Liabilities
-86.16% -0.9567 -71.29% -0.4372 -5.57% -0.5139 -- -0.2553
Operating Profit To Total Liabilities
-89.51% -0.766 -183.31% -0.2346 20.01% -0.4042 -- -0.0828
Operating Capacity
Inventory Turnover(T)
4.99% 1.2308 51.86% 0.8158 -36.4% 1.1724 -- 0.5372
Current Assets Turnover(T)
36.84% 0.1241 69.69% 0.0627 -37.77% 0.0907 -- 0.037
Fixed Assets Turnover(T)
-1.36% 3.4744 47.15% 2.3404 -18.26% 3.5224 -- 1.5905
Total Assets Turnover(T)
25.73% 0.0894 75.3% 0.0495 -27.94% 0.0711 -- 0.0282
Growth Ability
Operating Revenue GR 3Y
-79.68% 286.368% -- -- -- 1409.401% -- --
Gross Income GR 3Y
-82.01% 251.173% -- -- -- 1396.206% -- --
Operating Profit GR 3Y
-90.75% -31.479% -- -- -- -16.503% -- --
EBT GR 3Y
-103.37% -35.043% -- -- -- -17.231% -- --
Net Profit GR 3Y
-116.44% -32.442% -- -- -- -14.989% -- --
Net Profit Attributable To The Parent Company GR 3Y
-115.14% -33.285% -- -- -- -15.472% -- --
Total Assets GR 3Y
-79.62% 428.128% -- -- -- 2101.090% -- --
Share Equity Without Minority Interest GR 3Y
-81.39% 952.948% -- -- -- 5119.361% -- --
Equity GR 3Y
-79.28% 952.823% -- -- -- 4597.502% -- --
Total Liabilities GR 3Y
-103.11% -9.461% -- -- -- 304.279% -- --
Basic Earning Per Share GR 3Y
-65.28% 11.561% -- -- -- 33.293% -- --
Other Indicators
Currency Unit
港元港元港元港元

Q6、Q9、FY为累计季报:Q6 为中期报告;Q9 为第三季报;FY为年报。

环比数据来源于季报,环比 = (本期 - 上期)/上期 * 100%

公司概况 更多
杭州启明医疗器械股份有限公司是一家从事用于治疗心脏瓣膜疾病的微创医疗设备以及辅助仪器和设备的研发、制造和销售的中国公司。该公司的主要产品包括VenusA-Valve系统,VenusA-Plus系统,VenusA-Pilot系统,VenusP-Valve系统,TMVR瓣膜, TTVR瓣膜,瓣膜成形术球囊V8/TAV8及TriGUARD3脑栓塞保护仪器。
董事长: 曾敏
所属市场: 香港主板
上市日期: 2019/12/10
富途热股榜
港股美股沪深
交易热度搜索热度资讯热度
名称代码最新价涨跌幅

加载中...

自选
回到顶部